Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 4 | 14 | 5 | 248 | 130 |
| Accounts receivable | 65 | -30 | -243 | 197 | -53 |
| Other Working Capital | -1,478 | -714 | 278 | 731 | -381 |
| Other Operating Activity | -22,187 | -16,672 | -10,971 | -5,386 | -3,644 |
| Operating Cash Flow | $-23,596 | $-17,402 | $-10,931 | $-4,210 | $-3,948 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -4 | -14 | -3 | -6 |
| Purchase Of Investment | -23,369 | -26,015 | -13,207 | N/A | N/A |
| Sale Of Investment | 13,958 | 30,435 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,369 |
| Investing Cash Flow | $-9,417 | $4,416 | $-13,220 | $-3 | $1,363 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 1,692 | 0 | 146 |
| Debt Repayment | N/A | 0 | -1,906 | N/A | N/A |
| Common Stock Issued | 0 | 29,823 | 24,471 | 1,471 | 5,552 |
| Other Financing Activity | 2,241 | 7,444 | 14,212 | 574 | 145 |
| Financing Cash Flow | $2,241 | $37,267 | $38,469 | $2,045 | $5,844 |
| Exchange Rate Effect | 503 | 518 | 866 | -4 | -1 |
| Beginning Cash Position | 40,073 | 15,376 | 1,450 | 3,589 | 563 |
| End Cash Position | 9,804 | 40,175 | 16,634 | 1,417 | 3,821 |
| Net Cash Flow | $-30,772 | $24,281 | $14,318 | $-2,168 | $3,259 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,596 | -17,402 | -10,931 | -4,210 | -3,948 |
| Capital Expenditure | -6 | -4 | -14 | -3 | -6 |
| Free Cash Flow | -23,602 | -17,406 | -10,945 | -4,212 | -3,954 |